Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

US Healthcare Ishares ETF (NY: IYH )

60.65 +0.48 (+0.80%)
Official Closing Price Updated: 6:30 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 204,235
Open 60.17
Bid (Size) 59.86 (33)
Ask (Size) 61.80 (32)
Prev. Close 60.17
Today's Range 59.90 - 60.74
52wk Range 54.09 - 66.59
Shares Outstanding 531,000
Dividend Yield 1.54%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen'
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency. 
Via Benzinga
Topics Government
Exposures Political Product Safety
What Lies In Store For Healthcare ETFs In Q3 Earnings?
The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. As such, various healthcare ETFs have benefited. 
Via Talk Markets
Topics ETFs

Performance

YTD
+4.30%
+4.30%
1 Month
-5.13%
-5.13%
3 Month
-7.21%
-7.21%
6 Month
-1.32%
-1.32%
1 Year
+11.84%
+11.84%

More News

Read More
Deere, Amgen, Copart And More: CNBC's 'Final Trades'
Via Benzinga
Defensive ETFs Shine Amid A Rough Start To September
Via Talk Markets
Topics ETFs
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
Via Benzinga
Delta Air Lines, Interactive Brokers And More: CNBC's 'Final Trades'
Via Benzinga
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Via Benzinga
Topics Government
Exposures Political
Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
Via The Motley Fool
'Barbarism:' AOC Unleashes Fury On US Healthcare System As People Are 'Choosing Between Medicine And Rent'
Via Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Via Talk Markets
Topics ETFs
Target, Apollo Global Management, Las Vegas Sands And More: CNBC's 'Final Trades'
Via Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
Via Benzinga
Pfizer's Dividend Yield Is 5.7%, Plus Humana And Shake Shack On CNBC's 'Final Trades'
Via Benzinga
Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy
Via Benzinga
Humana, Comerica, Cleveland-Cliffs, And More: CNBC's 'Final Trades'
Via Benzinga
Cisco, Burlington Stores, Broadcom And More On CNBC's 'Final Trades'
Via Benzinga
Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
Via Benzinga
Exposures Product Safety
All eyes on the Fed as inflation metrics give mixed signals
Via Talk Markets
Topics Economy
Exposures Interest Rates
Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout
Via Benzinga
4 Top-Ranked Sector ETFs To Buy In The Second Half
Via Talk Markets
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Via Benzinga
The 3 Most Promising Industries to Invest in for 2023’s Second Half
Via InvestorPlace
Stocks Flounder Despite Inflation Downtrend As Banking Crisis Emerges, But Outlook Remains Encouraging
Via Talk Markets
Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
Via The Motley Fool
Uncertainties On Fed Policy, Geopolitics, And Earnings Cloud 2023 Outlook, But Trends Are Promising
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.